Abcuro announces pre-clinical data on new immuno-oncology target
Member News
First in vivo validation of KLRG1 as a new cancer immunotherapy target
Related or similar articles
April 29, 2024
Lab Space Boston: Navigating Opportunities and Challenges
Hello, fellow science enthusiasts! If you're on the hunt for the perfect laboratory space in greater Boston and Cambridge, you've come to the right place. As experts in the field, we at Labshares know a thing or two about navigating the opportunities
Labshares News
December 9, 2021
Bulfinch Leases 40,000 Square Feet to Labshares
BOSTON & NEWTON, Mass.--(BUSINESS WIRE)--The Bulfinch Companies, Inc. (Bulfinch), a commercial real estate and investment firm, and Labshares Newton today announced the expansion of the life science and biotech co-working incubator at Chapel Bridge..
Labshares News
December 10, 2021
Labshares Newton Doubles Space for Emerging Biotech Startups
NEWTON, Mass.--(BUSINESS WIRE)--Labshares Newton celebrated today the opening of 19,000 square feet of new incubator lab space and expects to open another 6,000-foot lab in September. Labshares’ new space incorporates 12 private suites, 15 lab ...
Labshares News